KRA - GCP Applied Technologies Kraton drop as deals need Russian approval

Shares of GCP Applied Technologies (NYSE:GCP), which agreed to a $2.3B sale to Saint-Gobain in December, and Kraton Corp. (NYSE:KRA), which is being acquired by DL Chemical, fell at least party as they are companies involved in deals that require Russian approval, according to traders. GCP fell 0.7%, while Kraton dipped 0.1%. Investors may be concerned that a Russian invasion of Ukraine could have impact on deals that require Russian approval. Russian forces are now reportedly in the Kyiv area while air attacks continue In September, DL Chemical agreed to to buy Kraton  in a deal valued at $2.5B.  Kraton stockholders will receive $46.50 in cash for each share of Kraton common stock. Ortho Clinical Diagnostics (NASDAQ:OCDX) which agreed to a $6B sale to Quidel (NASDAQ:QDEL) in late December, is another deal that requires Russian approval, according to traders. Also see, Biden announces additional sanctions on Russia, pledges to defend NATO allies.

For further details see:

GCP Applied Technologies, Kraton drop as deals need Russian approval